Article
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study.
EBioMedicine - 1 Sept 2022
Ozonoff Al, Schaenman Joanna, Jayavelu Naresh Doni, Milliren Carly E, Calfee Carolyn S, Cairns Charles B, Kraft Monica, Baden Lindsey R, Shaw Albert C, Krammer Florian, van Bakel Harm, Esserman Denise A, Liu Shanshan, Sesma Ana Fernandez, Simon Viviana, Hafler David A, Montgomery Ruth R, Kleinstein Steven H, Levy Ofer, Bime Christian, Haddad Elias K, Erle David J, Pulendran Bali, Nadeau Kari C, Davis Mark M, Hough Catherine L, Messer William B, Higuita Nelson I Agudelo, Metcalf Jordan P, Atkinson Mark A, Brakenridge Scott C, Corry David, Kheradmand Farrah, Ehrlich Lauren I R, Melamed Esther, McComsey Grace A, Sekaly Rafick, Diray-Arce Joann, Peters Bjoern, Augustine Alison D, Reed Elaine F, Altman Matthew C, Becker Patrice M, Rouphael Nadine
Abstract excerpt
BACKGROUND: Better understanding of the association between characteristics of patients hospitalized with coronavirus disease 2019 (COVID-19) and outcome is needed to further improve upon patient management. METHODS: Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC) is a prospective, observational study of 1164 patients from 20 hospitals across the United States. Disease severity was assessed using a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.